Racial, Ethnic Disparities Seen in mAb Treatment for COVID-19
Monoclonal antibody treatment used infrequently among all racial, ethnic groups; Hispanics received mAbs less often than non-Hispanics
AI Model May Predict COVID-19 Outcomes for Critically Ill
Machine learning model incorporates data from 14 proteins derived from a single blood sample to predict survival in patients with COVID-19
BNT162b2 Vaccine Effective Against Severe COVID-19 in Adolescents
Two doses highly effective against COVID-19-related hospitalization and critical illness for those aged 12 to 18 years
WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased
Fewer than 10 percent of people in lower-income countries have received one dose of COVID-19 vaccine
COVID-19 Cases Surge Again in U.S. Nursing Homes
During the week ending Jan. 9, U.S. nursing homes reported more than 32,000 cases and 645 deaths among their residents
COVAX Program Has Now Sent 1 Billion Vaccines to Poorer Nations
Thirty-six of the organization's 194 member countries have still only vaccinated 10 percent of their populations
Factors ID’d for Eventual Surgery in Patients With Appendicitis
Presence of an appendicolith increases risk for undergoing appendectomy after starting antibiotic therapy for acute appendicitis
Epstein-Barr Virus Suspected as Cause of Multiple Sclerosis
Risk for MS increased 32-fold following EBV infection, but not following infection with other viruses, including cytomegalovirus
Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19
Adding a P2Y12 inhibitor to a therapeutic dose of heparin does not improve outcomes among non-critically ill patients hospitalized for COVID-19
White House Launches Website for Free Home COVID-19 Tests a Day Ahead of Schedule
Early launch due to 'beta testing'; website currently working at 'limited capacity' ahead of official Wednesday debut
